Micreos endolysin based technology is the world's first targeted antibacterial product, set to replace antibiotics. Killing only the unwanted bacteria - including antibiotic resistant strains - while preserving the beneficial bacteria.
NOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated.